| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |